🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/02/2020 | 81,93 | 82,06 | 81,06 | 81,35 | -0,48% | 1,22% | 10.252.689 |
| 10/02/2020 | 81,18 | 82,04 | 81,05 | 81,74 | +0,68% | 1,22% | 10.590.983 |
| 07/02/2020 | 81,96 | 82,00 | 80,94 | 81,18 | -0,70% | 1,29% | 11.419.427 |
| 06/02/2020 | 82,08 | 82,28 | 81,36 | 81,76 | -0,17% | 1,13% | 16.110.170 |
| 05/02/2020 | 80,80 | 82,77 | 80,15 | 81,90 | -2,86% | 3,24% | 29.290.133 |
| 04/02/2020 | 84,38 | 85,11 | 84,03 | 84,31 | +1,17% | 1,29% | 15.091.305 |
| 03/02/2020 | 82,10 | 84,18 | 82,10 | 83,34 | +2,22% | 2,53% | 9.729.318 |
| 31/01/2020 | 82,42 | 82,70 | 81,11 | 81,53 | -1,23% | 1,93% | 9.621.583 |
| 30/01/2020 | 82,97 | 83,14 | 82,25 | 82,54 | -0,85% | 1,07% | 11.016.471 |
| 29/01/2020 | 82,63 | 84,12 | 82,47 | 83,24 | +1,15% | 2,00% | 8.511.227 |
| 28/01/2020 | 82,48 | 82,74 | 81,97 | 82,30 | +0,17% | 0,94% | 9.496.347 |
| 27/01/2020 | 81,20 | 82,55 | 80,83 | 82,16 | +0,14% | 2,12% | 10.847.534 |
| 24/01/2020 | 84,57 | 84,76 | 81,66 | 82,04 | -2,91% | 3,67% | 14.954.960 |
| 23/01/2020 | 85,55 | 85,55 | 84,22 | 84,50 | -1,22% | 1,56% | 13.198.093 |
| 22/01/2020 | 86,04 | 86,32 | 85,52 | 85,54 | -0,36% | 0,93% | 7.800.474 |
| 21/01/2020 | 86,56 | 86,80 | 85,60 | 85,85 | -1,10% | 1,39% | 10.022.129 |
| 17/01/2020 | 87,10 | 87,43 | 86,70 | 86,80 | -0,23% | 0,84% | 10.131.226 |
| 16/01/2020 | 87,65 | 87,84 | 86,88 | 87,00 | -0,39% | 1,10% | 7.252.474 |
| 15/01/2020 | 85,97 | 87,41 | 85,96 | 87,35 | +1,79% | 1,69% | 9.614.038 |
| 14/01/2020 | 85,18 | 85,81 | 84,80 | 85,81 | +0,47% | 1,19% | 8.625.669 |
| 13/01/2020 | 85,42 | 85,52 | 84,94 | 85,41 | -0,02% | 0,68% | 10.261.492 |
| 10/01/2020 | 85,61 | 85,98 | 85,35 | 85,43 | +0,17% | 0,74% | 5.945.304 |
| 09/01/2020 | 84,88 | 85,93 | 84,71 | 85,29 | +0,88% | 1,43% | 9.714.750 |
| 08/01/2020 | 85,01 | 85,40 | 84,36 | 84,54 | -0,67% | 1,22% | 15.200.506 |
| 07/01/2020 | 86,64 | 86,95 | 85,04 | 85,11 | -2,66% | 2,20% | 11.132.275 |
| 06/01/2020 | 87,05 | 87,54 | 86,82 | 87,44 | +0,43% | 0,82% | 7.522.963 |
| 03/01/2020 | 86,53 | 87,85 | 86,36 | 87,07 | -0,86% | 1,72% | 5.903.698 |
| 02/01/2020 | 86,91 | 87,92 | 86,23 | 87,82 | +1,20% | 1,94% | 8.251.428 |
| 31/12/2019 | 86,76 | 86,82 | 86,30 | 86,78 | -0,09% | 0,60% | 4.710.760 |
| 30/12/2019 | 87,34 | 87,49 | 86,57 | 86,86 | -0,51% | 1,05% | 3.932.934 |